Evidence map›Paper›PMID 40428176›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Real-World Data: Implementation and Outcomes of Next-Generation Sequencing in the MENA Region.

Rami Mahfouz, Reine Abou Zeidane, Tasnim Diab, Ali Tarhini, Eman Sbaity, Houry Kazarian, Yomna El Zibaoui, Nour Sabiha Naji, Mounir Barake, Hazem I Assi

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rami MahfouzDepartment of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut P.O. Box 11-0236, Lebanon.
Reine Abou ZeidaneDepartment of Internal Medicine, Division of Hematology and Oncology, American University of Beirut Medical Center, Naef K Bassile Cancer Institute, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0004-5009-3150
Tasnim DiabDepartment of Internal Medicine, Division of Hematology and Oncology, American University of Beirut Medical Center, Naef K Bassile Cancer Institute, Beirut P.O. Box 11-0236, Lebanon.
Ali TarhiniFaculty of Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
Eman SbaityDepartment of General Surgery, American University of Beirut Medical Center, Beirut P.O. Box 11-0236, Lebanon.
Houry KazarianDepartment of Internal Medicine, Division of Hematology and Oncology, American University of Beirut Medical Center, Naef K Bassile Cancer Institute, Beirut P.O. Box 11-0236, Lebanon.
Yomna El ZibaouiFaculty of Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
Nour Sabiha NajiFaculty of Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0004-4761-7435
Mounir BarakeDepartment of Internal Medicine, Division of Hematology and Oncology, American University of Beirut Medical Center, Naef K Bassile Cancer Institute, Beirut P.O. Box 11-0236, Lebanon.
Hazem I AssiDepartment of Internal Medicine, Division of Hematology and Oncology, American University of Beirut Medical Center, Naef K Bassile Cancer Institute, Beirut P.O. Box 11-0236, Lebanon.ORCID 0000-0002-8483-0938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

molecular profilingNGSpersonalized medicineprecision medicinesequencingtargeted therapy

Identifiers

PMID40428176
PMCPMC12110402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.